The company said it disclosed changes to its Clearing House collateral fee schedule and pricing changes under Item 7.01 Regulation FD Disclosure on December 11, 2024.

8-KRegulation FD DisclosureFiled Dec 11, 2024Period of report Dec 11, 2024Summary published (UTC) Oct 29, 2026

Key points

AI summary

The company said it disclosed changes to its Clearing House collateral fee schedule and pricing changes under Item 7.01 Regulation FD Disclosure on December 11, 2024.
CME Group said it communicated changes to its Clearing House collateral fee schedule to Clearing Members on December 11, 2024 via Advisory Notice 24-383.
The company said it communicated pricing changes to clients on December 11, 2024 via Special Executive Report 9482.
The company said it posted copies of both notices on its website. It also said the Item 7.01 information is not deemed filed under Exchange Act Section 18 and is not incorporated by reference into other filings.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

December 11, 2024 Reg FD Disclosure Overview

The company said it disclosed changes to its Clearing House collateral fee schedule and pricing changes under Item 7.01 Regulation FD Disclosure on December 11, 2024.

Source · Based on the filing body and exhibits

Advisory Notice 24-383 to Clearing Members

CME Group said it communicated changes to its Clearing House collateral fee schedule to Clearing Members on December 11, 2024 via Advisory Notice 24-383.

Source · Based on the filing body and exhibits

Special Executive Report 9482 to Clients

The company said it communicated pricing changes to clients on December 11, 2024 via Special Executive Report 9482.

Source · Based on the filing body and exhibits

Notice Posting and Filing Treatment of Disclosed Information

The company said it posted copies of both notices on its website. It also said the Item 7.01 information is not deemed filed under Exchange Act Section 18 and is not incorporated by reference into other filings.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.